What portion of the cash balance is planned to be allocated to crypto assets, and which tokens will be used?
Portion of the cash balance to be allocated – up to 5 percent
Processa Pharmaceuticals disclosed that, as part of its new corporate‑treasury‑crypto initiative, it will earmark “up to 5 % of its cash balance” for investment in digital‑asset holdings. The company said the allocation will be made gradually and will be managed under a dedicated treasury‑management policy that is overseen by its finance team and external advisors.
Tokens that will be used – Bitcoin (BTC) and Ethereum (ETH)
The press release specifies that the crypto‑treasury program will focus on the two most‑liquid, market‑cap digital currencies:
| Token | Rationale given by Processa |
|---|---|
| Bitcoin (BTC) | “the leading store‑of‑value asset and the most widely recognized digital currency” |
| Ethereum (ETH) | “the primary smart‑contract platform, offering exposure to a broader ecosystem of decentralized applications and potential upside from network upgrades” |
Key points to note
- The 5 % ceiling is a maximum limit; the actual amount may be lower depending on market conditions, internal risk‑assessment outcomes, and the timing of the strategic investment round.
- The allocation will be held in a custodial arrangement with a qualified, insured crypto‑custody provider to meet the company’s security and compliance standards.
- Processa’s board will review the crypto‑treasury policy at least semi‑annually to ensure alignment with its broader financial‑growth objectives and to monitor any regulatory developments that could affect corporate crypto holdings.
Thus, Processa Pharmaceuticals plans to set aside up to 5 % of its cash balance for crypto assets, investing specifically in Bitcoin (BTC) and Ethereum (ETH) as part of its corporate‑treasury diversification strategy.